Annals of Oncology · 2020 · 52 citations · 21 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMetastasisCombination ChemotherapyMalignant NeoplasmsMetastatic Cancer ManagementMetastatic Disease TreatmentPancreatic CancerPancreatic DiseasesGemcitabine-based TherapyMetastatic Pancreatic CancerPancreatic Cancer PharmacotherapyPancreatic MetastasesPlacebo-controlled Efficacy Assessment
21
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2019 · 21K citations · Full text
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.8K citations · Full text
Medicine, Oncology, Pharmacology +13
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena et al. · New England Journal of Medicine · 2013 · 6.7K citations
Medicine, Oncology, Pharmacology +13